Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Beattie; David
Address:
Horsham, GB
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
8283362 Beta-2-adrenoreceptor agonists October 9, 2012
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
8273900 Organic compounds September 25, 2012
There are described cyclohexyl amide derivatives useful as corticotropin releasing factor (CRF.sub.1) receptor antagonists.
8067437 Beta-2-adrenoreceptor agonists November 29, 2011
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
7820694 Beta-2-adrenoreceptor agonists October 26, 2010
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
7745462 Quinoline-2-one derivatives for the treatment of airways diseases June 29, 2010
Compounds of formula I ##STR00001## in free or salt form, wherein --C--Y--, R.sup.1 and R.sup.2 are G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the .beta..sub.2-adrenoreceptor. Pharmaceut
7622483 .beta.2-adrenoceptor agonists November 24, 2009
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
6921757 Organic compounds July 26, 2005
Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals ##STR1##
6878721 Beta2-adrenoceptor agonists April 12, 2005
Compounds of formula ##STR1##in free or salt or solvate form, where Ar is a group of formula ##STR2##Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, their p










 
 
  Recently Added Patents
Memory device program window adjustment
Heating pad
Method and system for physical verification using network segment current
Developing device
Magnetic storage apparatus
Flexible organic light emitting device and manufacturing method thereof
Headphone
  Randomly Featured Patents
Torso protection assembly
Very low thermal budget channel implant process for semiconductors
Eyeglass retainer device
Removing effects of gain and phase mismatch in a linear amplification with nonlinear components (LINC) system
Optical system, imaging apparatus, and method for forming image by the optical system
System and method for laser beam expansion
Cap, reservoir and dropper assembly for bottles
Apparatus and method for an electromagnetic actuator with two orthogonal axes of motion
Techniques for use with device drivers in a common software environment
Process for preparing submicron/nanosize ceramic powders from precursors incorporated within a polymeric foam